Sagent Pharmaceuticals
Manufacturing · Illinois, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1901 N Roselle Rd Ste 450, Schaumburg, I...Phone Number
(847) 908-1600Website
www.sagentpharma.comRevenue
$291.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
2
1
1
About Sagent Pharmaceuticals
Sagent Pharmaceuticals is a biopharmaceutical company, specializing in generic injectables. The company was founded in 2006 and is headquartered in Schaumburg, Illinois.Explore more
Sagent Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sagent Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Sagent Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Sagent Pharmaceuticals recently announced quarterly report
Check if Sagent Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sagent Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Sagent Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Sagent Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Sagent Pharmaceuticals
Check out if Sagent Pharmaceuticals is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Sagent Pharmaceuticals
Compare insights from companies similar to Sagent Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sagent Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sagent Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sagent Pharmaceuticals.
Sagent Pharmaceuticals financials insights
Gather financial insights about Sagent Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Series A
$30M
2010
Series B
$40M
2011
Stock Offering
$92M
Sagent Pharmaceuticals Tech Stack
A closer look at the technologies used by Sagent Pharmaceuticals
Most Recent Scoops
Open Position
Hiring Plans
Sagent Pharmaceuticals has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Project
, according to a high-level source in LGL, has completed initiatives related to document drafting solutions software within the last twelve months.
Document Management, Software
Pain Point
Project
, according to a high-level source in LGL, is planning to remediate challenges related to process automation. Sagent Pharmaceuticals is planning to update workflow and increase headcount. The organization is currently evaluating various vendors.
Pain Point, Automation, Digital Technology, Pharmaceuticals
Pain Point
Project
Pain Point, Research & Development, Legal Affairs, Search, Legal Technology
Sagent Pharmaceuticals News & Media
Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.
SCHAUMBURG, Ill., July 7, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, and Qilu Pharmaceutical Co., Ltd. ("Qilu"), a leading vertically integrated pharmaceutical company based in China, today announced a strategic...A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval
MINNETONKA, Minn.--(BUSINESS WIRE)--A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex®, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL and 400 mcg per 100 mL in 0.9% sodium chloride in glass bottles by its partner Sagent Pharmaceuticals. Dexmedetomidine Hydrochloride Injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. DexmedetoSagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter
SCHAUMBURG, Ill., May 28, 2024 /PRNewswire/ -- Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL multi-dose vials). The product was distributed by Sagent Pharmaceuticals....Athenex assets sold in bankruptcy auction; top executives dismissed | wgrz.com
Schaumburg, Illinois-based Sagent Pharmaceuticals purchased assets from Athenex Pharmaceutical Division in a deal that closed June 30, according to the SEC filing.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sagent Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Sagent Pharmaceuticals is a biopharmaceutical company, specializing in generic injectables. The company was founded in 2006 and is headquartered in Schaumburg, Illinois.... Read More
